ONCTERNAL THERAPEUTICS INC (ONCT)

US68236P2065 - Common Stock

0.71  -0.43 (-37.72%)

After market: 0.76 +0.05 (+7.04%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to ONCT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 2.04. This target is 187.32% above the current price.
ONCT was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ONCT.
In the previous month the buy percentage consensus was at a similar level.
ONCT was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 0.712.022.042.042.10 - 184.51% 187.32% 187.32% 195.77%
Up and Down Grades
Date Firm Action Rating
2024-09-12 Brookline Capital Downgrade Buy -> Hold
2024-09-12 Northland Capital Markets Downgrade Outperform -> Market Perform
2024-08-12 HC Wainwright & Co. Maintains Buy -> Buy
2024-07-16 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-31 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-13 HC Wainwright & Co. Maintains Buy -> Buy
2024-04-15 HC Wainwright & Co. Maintains Buy -> Buy
2024-01-29 HC Wainwright & Co. Maintains Buy -> Buy
2023-12-27 HC Wainwright & Co. Reiterate Buy -> Buy
2023-12-04 Brookline Capital Upgrade Hold -> Buy
2023-09-18 HC Wainwright & Co. Upgrade Neutral -> Buy
2023-09-07 Cantor Fitzgerald Reiterate Neutral -> Neutral
2023-06-06 HC Wainwright & Co. Reiterate Neutral
2023-04-04 Cantor Fitzgerald Maintains Overweight
2023-04-04 Brookline Capital Downgrade Buy -> Hold
2023-04-04 Oppenheimer Downgrade Outperform -> Perform
2023-04-04 Maxim Group Downgrade Buy -> Hold
2023-04-04 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-03-22 Oppenheimer Maintains Outperform
2023-03-14 HC Wainwright & Co. Reiterate Buy
2022-12-22 Cantor Fitzgerald Initiate Overweight
2022-08-10 HC Wainwright & Co. Maintains Buy
2022-05-10 Maxim Group Initiate Buy
2022-02-24 BTIG Initiate Buy
2021-04-07 Oppenheimer Initiate Outperform
2021-03-30 Brookline Capital Initiate Buy
2021-03-12 HC Wainwright & Co. Maintains Buy